CoChat

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Obesity: a gender-view

Open access
Muscogiuri, G., Verde, L., Vetrani, C., Barrea, L., Savastano, S., Colao, A. · 2023 · Journal of Endocrinological Investigation

Abstract

PURPOSE: There is a growing awareness of the importance of understanding gender differences in obesity. The aim of this short review was to revise the current evidence on anthropometric characteristics and nutritional and pharmacological aspects of obesity from a gender perspective. METHODS: A literature search within PubMed was performed. Selected publications related to obesity and gender differences were reviewed. RESULTS: The prevalence of obesity among men is higher than in women, but women have a higher percentage of body fat content compared to men, and gender appears to be an important factor in the manifestation of central (android) or peripheral (gynoid) obesity. In addition, while in most clinical trials, women are still underrepresented, in clinical registration trials of anti-obesity drugs, women are commonly up-represented and gender-specific analysis is uncommon. Considering that adipose tissue is one of the factors affecting the volume of distribution of many drugs, mainly lipophilic drugs, gender differences might be expected in the pharmacokinetics and pharmacodynamics of anti-obesity drugs. Indeed, although Liraglutide 3 mg, a long-acting glucagon-like peptide-1 receptor agonist, and naltrexone/bupropion display lipophilic properties, currently, a gender-dose adjustment for both these drugs administration is not recommended. In addition, despite that predicted responders to treatment offer substantial opportunities for efficient use, especially of expensive new therapies, such as anti-obesity drugs, data on gender differences to identify early responders to both these have not yet been investigated. Finally, bariatric surgery gender disparity reflects healthcare practices. Weight loss similar, but differing effects: women need more correction and face psychology challenges; men have worse physiology and fewer comorbidity improvements. CONCLUSION: Gender differences exist in obesity prevalence and phenotype, body fat distribution, drug efficacy, clinical trial representation, and different secondary effects of bariatric surgery. Gender is an important variable in obesity analysis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40618-023-02196-z

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Gender differences in body composition and eating behavior. Subcutaneous adipose tissue presents higher concentrations of estrogen and progesterone receptors than androgen receptors. Conversely, visceral adipose tissue has a higher concentration of androgen receptors. Hormonal differences may explain the sexual dimorphism of adiposity between men and women: women have more adipose tissue than men and a peripheral distribution of fat mass, while men have a central distribution of fat mass. Sex hormones also influence food preferences: women prefer more carbohydrate-rich and sweet foods, while men prefer more fat-rich foods. ARs androgen receptors; ERs estrogen receptors; PRs progesterone receptors
Fig. 1 Gender differences in body composition and eating behavior. Subcutaneous adipose tissue presents higher concentrations of estrogen and progesterone receptors than androgen receptors. Conversely, visceral adipose tissue has a higher concentration of androgen receptors. Hormonal differences may explain the sexual dimorphism of adiposity between men and women: women have more adipose tissue than men and a peripheral distribution of fat mass, while men have a central distribution of fat mass. Sex hormones also influence food preferences: women prefer more carbohydrate-rich and sweet foods, while men prefer more fat-rich foods. ARs androgen receptors; ERs estrogen receptors; PRs progesterone receptorsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

See all 209

Metadata

Authors
Muscogiuri, G., Verde, L., Vetrani, C., Barrea, L., Savastano, S., & Colao, A.
Affiliations
  • University of Naples Federico II (IT)
  • Federico II University Hospital (IT)
Corresponding author
Muscogiuri, G.
Venue
Journal of Endocrinological Investigation
Published
2023-09-23
Volume
47
Issue
2
Pages
299-306
ISSN
  • 0391-4097 (ISSN-L)
  • 1720-8386
OpenAlex
W4386982751
Cited by
164
References
64
Citations by year
2026: 63 · 2025: 66 · 2024: 34 · 2023: 1
FWCI
5.96
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Endocrinological Investigation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Università degli Studi di Napoli Federico II
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity and Health Practices
Keywords
obesity, gender differences, body fat distribution, android obesity, gynoid obesity, anti-obesity drugs, pharmacokinetics, pharmacodynamics, liraglutide, naltrexone/bupropion, GLP-1 receptor agonists, bariatric surgery outcomes, obesity prevalence
MeSH terms
Liraglutide, Female, Humans, Male, Obesity, Weight Loss, Anti-Obesity Agents, Bariatric Surgery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Obesity: a gender-view. https://app.cochat.ai/papers/10.1007/s40618-023-02196-z
The paper
Muscogiuri, G., Verde, L., Vetrani, C., Barrea, L., Savastano, S., & Colao, A. (2023). Obesity: a gender-view. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-023-02196-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.